Table 2.
Prevalence of dyslipidemia and its subtypes (%).
| Variables | Total | <50.0 mg/day | 50.0–<100.0 mg/day | 100.0–<150.0 mg/day | 150.0–<200.0 mg/day | 200.0–<250.0 mg/day | 250.0–<300.0 mg/day | 300.0–<350.0 mg/day | 350.0–<400.0 mg/day | 400.0–<450.0 mg/day | 450.0–<500.0 mg/day | ≥500.0 mg/day | p-trend * |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dyslipidemia *,‡ | 37.5 | 33.3 | 36.8 | 36.4 | 35.7 | 41.2 | 35.8 | 37.4 | 39.7 | 35.9 | 38.0 | 41.1 | 0.025 |
| Hypercholesterolemia *,‡ | 9.6 | 8.0 | 9.6 | 6.7 | 8.8 | 11.1 | 11.3 | 8.5 | 7.3 | 9.0 | 11.3 | 13.6 | 0.004 |
| Hypertriglyceridemia | 15.2 | 13.3 | 16.8 | 14.1 | 16.1 | 18.7 | 13.2 | 14.8 | 14.2 | 11.7 | 10.0 | 17.8 | 0.863 |
| HDL-hypocholesterolemia | 21.1 | 19.5 | 22.4 | 23.7 | 20.0 | 22.4 | 18.4 | 22.8 | 22.1 | 19.7 | 20.7 | 20.1 | 0.584 |
| LDL-hypercholesterolemia *,‡ | 12.7 | 9.6 | 10.1 | 9.4 | 11.8 | 14.6 | 13.4 | 12.4 | 13.0 | 13.9 | 11.3 | 18.3 | <0.001 |
* Showed a significant difference in the prevalence of dyslipidemia and its four subtypes tested by Chi-square test (p < 0.05). ‡ Showed an uptrend tested by the Cochran-Armitage test for trend (p < 0.05).